HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)-Reference-Cited by-同舟云学术

HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)

Published:2013-10-14 Issue:11 Volume:92 Page:1313-1322
ISSN:0001-6349
Container-title:Acta Obstetricia et Gynecologica Scandinavica
language:en
Short-container-title:Acta Obstet Gynecol Scand

Author:

Antonsen Sofie L.¹,Høgdall Estrid²,Christensen Ib J.,Lydolph Magnus³,Tabor Ann,Loft Jakobsen Annika⁴,Fagö-Olsen Carsten L.¹,Andersen Erik S.⁵,Jochumsen Kirsten⁶,Høgdall Claus¹

Affiliation:

1. Gynecologic Clinic; Rigshospitalet, Copenhagen University Hospital; Copenhagen; Denmark

2. Department of Pathology; Danish Cancer Biobank; Herlev University Hospital; Herlev; Denmark

3. Division of Microbiology and Diagnostics; Department of Clinical Biochemistry and Immunology; Statens Serum Institute; Copenhagen; Denmark

4. Department of Clinical Physiology, Nuclear Medicine, and Positron Emission Tomography; Rigshospitalet, Copenhagen University Hospital; Copenhagen; Denmark

5. Department of Gynecology and Obstetrics; Aalborg University Hospital; Aalborg; Denmark

6. Department of Gynecology and Obstetrics; Odense University Hospital; Odense; Denmark

Publisher

Wiley

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aogs.12235/fullpdf

Reference41 articles.

1. Endometrial cancer;Amant;Lancet,2005

2. HE4 is an independent prognostic marker in endometrial cancer patients;Mutz-Dehbalaie;Gynecol Oncol,2012

3. Patients with atypical hyperplasia of the endometrium should be treated in oncological centers;Antonsen;Gynecol Oncol,2012